Adma Biologics Inc’s filing revealed that its President,CEO, and Interim CFO Grossman Adam S unloaded Company’s shares for reported $1.07 million on Jun 14 ’24. In the deal valued at $10.72 per share,100,000 shares were sold. As a result of this transaction, Grossman Adam S now holds 2,081,475 shares worth roughly $22.9 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ELMS STEVE sold 411,829 shares, generating $2,503,920 in total proceeds. Upon selling the shares at $6.08, the Director now owns 2,115,671 shares.
Before that, ELMS STEVE sold 49,887 shares. Adma Biologics Inc shares valued at $299,821 were divested by the Director at a price of $6.01 per share. As a result of the transaction, ELMS STEVE now holds 2,527,500 shares, worth roughly $27.8 million.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Friday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 2.71% to $11.00. Over the last five days, the stock has gained 2.04%. Adma Biologics Inc shares have risen nearly 143.36% since the year began. Nevertheless, the stocks have risen 178.48% over the past one year. While a 52-week high of $10.99 was reached on 06/21/24, a 52-week low of $3.06 was recorded on 01/03/24. SMA at 50 days reached $8.46, while 200 days put it at $5.53. A total of 7.45 million shares were traded, compared to the trading of 2.15 million shares in the previous session.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 10.71, which if violated will result in even more drops to 10.43. On the upside, there is a resistance level at 11.14. A further resistance level may holdings at 11.29. The Relative Strength Index (RSI) on the 14-day chart is 78.53, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 0.00%. Stochastics %K at 88.27% indicates the stock is a selling.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
